Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Karawajew

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Leukemia|August 1, 1997
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cellsL Karawajew, C Wuchter, V Ruppert, et al.
Anti-Cancer Drug Design|May 17, 2001
Role of crown-like side chains in the biological activity of substituted-phenoxazone drugsL Karawajew, E N Glibin, V Y Maleev, et al.
Blood|April 1, 1996
Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14R R Schumann, D Pfeil, N Lamping, et al.
British Journal of Haematology|August 10, 2000
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemiaC Wuchter, L Karawajew, V Ruppert, et al.
Gene Therapy|April 15, 2003
Coexpression of p21(WAF1/CIP1) in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expressionG Wolff, A Schumacher, A K Nuessler, et al.
Leukemia|June 22, 2001
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activityC Wuchter, D Krappmann, Z Cai, et al.
Leukemia|December 22, 1999
Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogeneticsC Wuchter, L Karawajew, V Ruppert, et al.
Blood|July 1, 1995
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesisS R Goan, I Fichtner, U Just, et al.
Leukemia|November 21, 2008
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after inductionR Ratei, G Basso, M Dworzak, et al.
Haematologica|February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotypingC Wuchter, R Ratei, G Spahn, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Leukemia|August 1, 1997
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cellsL Karawajew, C Wuchter, V Ruppert, et al.
Anti-Cancer Drug Design|May 17, 2001
Role of crown-like side chains in the biological activity of substituted-phenoxazone drugsL Karawajew, E N Glibin, V Y Maleev, et al.
Blood|April 1, 1996
Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14R R Schumann, D Pfeil, N Lamping, et al.
British Journal of Haematology|August 10, 2000
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemiaC Wuchter, L Karawajew, V Ruppert, et al.
Gene Therapy|April 15, 2003
Coexpression of p21(WAF1/CIP1) in adenovirus vector transfected human primary hepatocytes prevents apoptosis resulting in improved transgene expressionG Wolff, A Schumacher, A K Nuessler, et al.
Leukemia|June 22, 2001
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activityC Wuchter, D Krappmann, Z Cai, et al.
Leukemia|December 22, 1999
Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogeneticsC Wuchter, L Karawajew, V Ruppert, et al.
Blood|July 1, 1995
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesisS R Goan, I Fichtner, U Just, et al.
Leukemia|November 21, 2008
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after inductionR Ratei, G Basso, M Dworzak, et al.
Haematologica|February 27, 2001
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotypingC Wuchter, R Ratei, G Spahn, et al.
Pageof 5